Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Introduction to a Treatment for Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Speakers: Nitasha Sarswat, MDJignesh Patel, MD, PhD, FACC, FRCP, FAST
Duration: 20 minutes
Presented on: September 16, 2019
*This session is not eligible for AMA PRA Category 1 CreditsTM
Nitasha Sarswat, MD
Nitasha Sarswat, MDNitasha Sarswat, MD, is an assistant professor in the Section of Cardiology of the Division of Advanced Heart Failure and Transplantation at the University of Chicago in Chicago, Illinois, and director of the Cardiac Amyloidosis Program at The University of Chicago Medicine. Dr Sarswat received her medical degree from Northwestern University Feinberg School of Medicine in Chicago. She completed her internal medicine residency at New York University Hospitals in New York, New York, and served as a postdoctoral research fellow in advanced heart failure and transplantation at Albert Einstein College of Medicine/Montefiore Medical Center in Bronx, New York; fellow in cardiovascular disease at UMDNJ Hospitals in Camden, New Jersey; and fellow in advanced heart failure and transplantation at Massachusetts General Hospital in Boston, MA.
Dr Sarswat is a member of such organizations as the American Heart Association, American College of Cardiology, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, and International Society for Heart and Lung Transplantation.
Dr Sarswat has authored or co-authored dozens of peer-reviewed articles on advanced heart failure, mechanical circulatory support, and transplantation. She serves as a principal investigator for clinical trials and has given presentations at facilities and professional society meetings locally and nationally. Her clinical interests include cardiac amyloidosis, cardiac sarcoidosis, and hemodynamics.
Jignesh Patel, MD, PhD, FACC, FRCP, FAST
Jignesh Patel, MD, PhD, FACC, FRCP, FASTJignesh Patel, MD, PhD is the Medical Director of the Heart Transplant Program and Director of the Cardiac Amyloid Program at Cedars-Sinai Heart Institute. He earned his bachelor’s degree with honors and medical degree at the University of Cambridge. He earned his doctorate in vascular biology and physiology at UCLA. After becoming a member of the Royal College of Physicians (MRCP) in the United Kingdom, Dr. Patel pursued internal medicine residency at the Cleveland Clinic Foundation. He subsequently completed training in cardiovascular diseases in conjunction with his doctorate in the Subspecialty Training and Advanced Research (STAR) Program at UCLA, where he also served as a clinical instructor and chief cardiology fellow. He is board certified in cardiovascular disease and in heart failure and transplant cardiology and trained in nuclear cardiology. He has had a longstanding interest in all aspects of cardiovascular disease with special expertise in the management of patients with advanced heart failure and following cardiac transplantation. Dr. Patel has been the principal investigator or co-investigator of more than 75 research projects in areas related to heart failure and cardiac transplantation, including clinical trials of novel immunosuppressive agents, non-invasive technologies for the detection of rejection and multi-center trials of device therapy in congestive heart failure. His research into these and other areas has resulted in more than 100 articles in peer reviewed publications, several books chapters and more than 400 abstracts. He is a reviewer for several journals. He also has lectured extensively around the world on heart failure, transplantation and immunosuppression.